Loading...

Fixation Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL 48€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical data sheet

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  2. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  3. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  4. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  5. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  6. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  7. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  8. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  9. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  10. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  11. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  12. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  13. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  14. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  15. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  16. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  17. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  18. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  19. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  20. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  21. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  22. Chan L, et al. 2022. Cells. 12: . PubMed
  23. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  24. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  25. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  26. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  27. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  28. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  29. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  30. Zander R, et al. 2022. Immunity. 55:475. PubMed
  31. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  32. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  33. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  34. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  35. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  36. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  37. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  38. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  39. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  40. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  41. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  42. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  43. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  44. Wang H, et al. 2023. Nature. 615:339. PubMed
  45. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  46. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  47. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  48. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  49. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  50. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  51. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  52. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  53. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  54. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  55. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  56. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  57. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  58. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  59. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  60. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  61. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  62. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  63. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  64. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  65. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  66. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  67. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  68. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  69. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  70. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  71. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  72. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  73. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  74. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  75. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  76. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  77. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  78. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  79. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  80. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  81. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  82. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  83. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  84. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  85. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  86. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  87. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  88. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  89. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  90. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  91. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  92. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  93. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  94. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  95. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  96. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  97. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  98. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  99. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  100. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  101. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  102. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  103. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  104. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  105. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  106. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  107. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  108. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  109. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  110. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  111. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  112. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  113. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  114. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  115. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  116. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  117. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  118. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  119. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  120. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  121. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  122. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  123. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  124. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  125. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  126. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  127. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  128. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  129. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  130. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  131. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  132. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  133. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  134. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  135. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  136. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  137. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  138. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  139. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  140. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  141. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  142. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  143. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  144. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  145. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  146. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  147. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  148. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  149. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  150. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  151. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  152. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  153. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  154. Ma K, et al. 2022. iScience. 25:104347. PubMed
  155. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  156. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  157. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  158. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  159. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  160. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  161. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  162. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  163. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  164. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  165. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  166. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  167. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  168. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  169. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  170. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  171. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  172. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  173. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  174. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  175. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  176. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  177. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  178. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  179. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  180. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  181. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  182. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  183. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  184. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  185. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  186. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  187. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  188. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  189. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  190. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  191. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  192. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  193. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  194. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  195. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  196. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  197. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  198. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  199. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  200. Wang X, et al. 2022. Elife. 11:. PubMed
  201. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  202. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  203. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  204. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  205. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  206. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  207. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  208. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  209. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  210. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  211. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  212. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  213. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  214. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  215. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 07.25.2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account